Reported 1 day ago
Bank of America has downgraded Centene Corporation's stock from 'Neutral' to 'Underperform,' lowering its price target from $52 to $30 per share. The downgrade is attributed to concerns over Donald Trump's recently passed One Big Beautiful Bill Act, which is expected to impact Medicaid and ACA exchanges negatively. Despite a 17% revenue increase in Q1 2025, analysts foresee more downside risks for Centene in 2026, especially with potential expiration of exchange subsidies.
Source: YAHOO